| Elvis Castillo Garcia, MD | |
|
38051 Market Sq, Zephyrhills, FL 33542-7504 | |
| (813) 780-8085 | |
| (813) 355-5042 |
| Full Name | Elvis Castillo Garcia |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 18 Years |
| Location | 38051 Market Sq, Zephyrhills, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285829564 | NPI | - | NPPES |
| 003704700 | Medicaid | FL | |
| P01056132 | Other | FL | R&R MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | ME104548 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Tampa | Tampa, FL | Hospital |
| Adventhealth Wesley Chapel | Wesley chapel, FL | Hospital |
| Florida Hospital Zephyrhills | Zephyrhills, FL | Hospital |
| Florida Hospital Carrollwood | Tampa, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Medical Clinic Llc | 9931003068 | 368 |
News Archive
A new study conducted at the University of Worcester and published in The Journal of Steroid Biochemistry and Molecular Biology, has found low fat diets decrease men's testosterone levels by 10-15%.
A new study used deep learning with image recognition technology to trace the emergence of variants with increased viral fitness. Higher fitness leads to rapid expansion of these lineages in the areas where they are introduced. This type of study could facilitate the development of more effective antibodies and vaccines to help contain the pandemic.
Patients with mild to moderate Alzheimer's disease (AD) who received supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA), believed to possibly reduce the risk of AD, did not experience a reduction in the rate of cognitive and functional decline, compared to patients who received placebo, according to a study in the November 3 issue of JAMA, a theme issue on aging.
Results of a pre-clinical study of leconotide, an investigative calcium channel blocker, shows it has the potential to be safe, selective, and efficacious as a new non-opioid treatment for pain relief. It also holds promise in multiple drug delivery options including nasal spray, transdermal patch, and pills. Data were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.
CAQH announced today that BlueCross BlueShield of Tennessee has achieved certification for its implementation of the CAQH Committee on Operating Rules for Information Exchange Phase II rules. The certification will benefit more than 3 million insured members of the Tennessee health plan.
› Verified 6 days ago
| Entity Name | Florida Medical Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821055690 PECOS PAC ID: 9931003068 Enrollment ID: O20031120000962 |
News Archive
A new study conducted at the University of Worcester and published in The Journal of Steroid Biochemistry and Molecular Biology, has found low fat diets decrease men's testosterone levels by 10-15%.
A new study used deep learning with image recognition technology to trace the emergence of variants with increased viral fitness. Higher fitness leads to rapid expansion of these lineages in the areas where they are introduced. This type of study could facilitate the development of more effective antibodies and vaccines to help contain the pandemic.
Patients with mild to moderate Alzheimer's disease (AD) who received supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA), believed to possibly reduce the risk of AD, did not experience a reduction in the rate of cognitive and functional decline, compared to patients who received placebo, according to a study in the November 3 issue of JAMA, a theme issue on aging.
Results of a pre-clinical study of leconotide, an investigative calcium channel blocker, shows it has the potential to be safe, selective, and efficacious as a new non-opioid treatment for pain relief. It also holds promise in multiple drug delivery options including nasal spray, transdermal patch, and pills. Data were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.
CAQH announced today that BlueCross BlueShield of Tennessee has achieved certification for its implementation of the CAQH Committee on Operating Rules for Information Exchange Phase II rules. The certification will benefit more than 3 million insured members of the Tennessee health plan.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elvis Castillo Garcia, MD 38135 Market Sq, Zephyrhills, FL 33542-7505 Ph: (813) 528-4975 | Elvis Castillo Garcia, MD 38051 Market Sq, Zephyrhills, FL 33542-7504 Ph: (813) 780-8085 |
News Archive
A new study conducted at the University of Worcester and published in The Journal of Steroid Biochemistry and Molecular Biology, has found low fat diets decrease men's testosterone levels by 10-15%.
A new study used deep learning with image recognition technology to trace the emergence of variants with increased viral fitness. Higher fitness leads to rapid expansion of these lineages in the areas where they are introduced. This type of study could facilitate the development of more effective antibodies and vaccines to help contain the pandemic.
Patients with mild to moderate Alzheimer's disease (AD) who received supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA), believed to possibly reduce the risk of AD, did not experience a reduction in the rate of cognitive and functional decline, compared to patients who received placebo, according to a study in the November 3 issue of JAMA, a theme issue on aging.
Results of a pre-clinical study of leconotide, an investigative calcium channel blocker, shows it has the potential to be safe, selective, and efficacious as a new non-opioid treatment for pain relief. It also holds promise in multiple drug delivery options including nasal spray, transdermal patch, and pills. Data were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.
CAQH announced today that BlueCross BlueShield of Tennessee has achieved certification for its implementation of the CAQH Committee on Operating Rules for Information Exchange Phase II rules. The certification will benefit more than 3 million insured members of the Tennessee health plan.
› Verified 6 days ago
Dr. Amarilis Torres, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 38135 Market Sq Ste 105, Zephyrhills, FL 33542 Phone: 813-715-1934 Fax: 813-355-5059 | |
Alejandro Carvallo, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 36763 Eiland Blvd Ste 103, Zephyrhills, FL 33542 Phone: 813-994-3389 Fax: 813-355-5051 | |
Miss Barbara Helena Czelusniak, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 38184 Medical Center Ave, Zephyrhills, FL 33540 Phone: 813-782-1637 Fax: 813-780-9664 | |
Jeralyn A Allen, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 38135 Market Sq, Zephyrhills, FL 33542 Phone: 813-780-2155 Fax: 813-355-5017 | |
U Khin, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 37924 Medical Arts Ct, Zephyrhills, FL 33541 Phone: 813-779-1900 Fax: 813-779-8383 | |
Dr. Pramati Reddy Kumbha, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 6239 Fort King Rd, Zephyrhills, FL 33542 Phone: 813-783-3020 | |
Maher Salam, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6340 Fort King Rd, Zephyrhills, FL 33542 Phone: 813-782-6116 Fax: 813-780-1015 |